Editas Medicine, Inc.
EDITBiotechnology
$2.93−0.68%As of Oct 29vs prior close
- Market cap
- $450M
- P/E (TTM)
- –
- From 52W high
- −21.87%
- EPS (LTM)
- -$0.66
- Revenue (LTM)
- $47M
- Net margin
- -157.32%
- Dividend yield
- 0.00%
Nomior Score
16
Steady ProfileSpeculativeBottom 5% of the scored universe
Growth34
Quality36
Value34
Momentum31
Resilience19
Growth
+23.52%revenue a year over 9 fiscal years
YE16 $6.1MLTM $47M
Connections
Revenue to profitQ2 YE26
The operating loss was 156% of revenue, narrower by 1285 pts on a year.
Who owns it
2funds